Medican Enterprises Inc

As of March 31, 2015, Medican Enterprises Inc carries a market capitalization of 9.91M, placing it among publicly traded companies globally. Its enterprise value stands at 17.68M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2015, Medican Enterprises Inc has 47.21M shares outstanding.

These figures are as of March 31, 2015.

As of March 31, 2015, Medican Enterprises Inc maintains a current ratio of 0.01, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2015. Return on assets (ROA) is negative at -45,090.46, reflecting losses generated across the asset base. The company generates approximately - - in revenue per employee across its workforce of 2.50, a quick read on workforce productivity versus industry peers.

As of the close on October 22, 2026, Medican Enterprises Inc's stock has declined approximately 99.00% over the past 52 weeks. The 50-day moving average sits at -NaN, while the 200-day moving average is 0.00.

Over the twelve months ended March 31, 2015, Medican Enterprises Inc generated - - in revenue and converted that into -134.80M in net income, yielding earnings per share of -17.92. EBITDA reached -32.61M, while operating income came in at -32.72M.

As of March 31, 2015, Medican Enterprises Inc holds 9,398.00 in cash and equivalents against 7.77M in total debt, resulting in a net debt position of 7.76M. Total book value stands at -114.03M, with working capital of -9.66M providing operational flexibility.

Medican Enterprises Inc produced -3.01M in operating cash flow over the twelve months ended March 31, 2015.

These figures cover the twelve months ended March 31, 2015. Free cash flow yield is negative at -190.85: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -28.33, meaning Medican Enterprises Inc raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Medican Enterprises Inc's most recent stock split took place on April 20, 2015 with a 10:1 split ratio.

As of March 31, 2015, Medican Enterprises Inc has an Altman Z-Score of -4,783.70, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.